Financial Times - Nov 7
Nov 7 (Reuters) -The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- AstraZeneca's top China executive detained by authorities
- UK competition regulator drops Unilever investigation into "green" claims
- JD Wetherspoon warns of near £60mn jump in taxes and costs following UK Budget
- Reeves insists she will not be "coming back with more tax increases"
Overview
- AstraZeneca's AZN.L China president Leon Wang has been detained by Chinese authorities in an investigation related to the alleged illegal import and sale of cancer drug Imjudo.
- The Competition and Markets Authority, the UK's competition regulator, closed an investigation into whether Unilever ULVR.L overstated how "green" some of its products were, after the consumer goods company made changes to some of its packaging.
- JD Wetherspoon JDW.L, one of Britain's biggest high street employers, said it is facing a near 60 million pound($77.3 million) increase in taxes and business costs and that the UK hospitality sector will be forced to raise prices following the recent Budget.
- UK's finance minister Rachel Reeves said she will not "be coming back with more tax increases or more borrowing" before the end of the current parliament.
($1 = 0.7760 pounds)
(Compiled by Bengaluru newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
